Bruker Spatial Biology

A New Era of Understanding Awaits: Bruker Spatial Biology is leading the way in comprehensive spatial solutions, offering the tools you need to answer your unique Spatial Biology questions. 🔬 From proteomics, transcriptomics, and spatial multiomics, our industry-leading platforms are here to unlock the full potential of your research with the right solutions for your research needs. Join us, and discover how we’re shaping the future of Spatial Biology: https://lnkd.in/g3FumKNx #SpatialBiology #Proteomics #Transcriptomics #Genomics #ResearchInnovation #BrukerSpatialBiology #LifeSciences

Save the date, Thursday, December 12 to learn from John Lyssand how Discovery Multiomics on GeoMx® Digital Spatial Profiler (DSP) is redefining spatial biology with integrated insights of health and disease from tissue samples. With unbiased plex, GeoMx offers unmatched discovery potential with the whole transcriptome and 570+ proteins from the same slide. Join us to explore case studies and applications of Discovery Multiomics: Pathways dynamics in human developmental discovery research Disease mechanisms in pancreatic cancer cohort analysis Biomarker discovery associated with patient survival in Head and Neck cancer Save your seat! Webinar: https://lnkd.in/gZRcC-ek #DiscoveryMultiomics #SpatialMultiomics #GeoMxDSP

In honor of Lung Cancer Awareness Month, this #FridayRead highlights how Discovery Multiomics with GeoMx DSP is advancing our understanding of drug effects on the tumor microenvironment (TME). Merck KGaA researchers leveraged GeoMx DSP’s multiomic profiling to interrogate clinically relevant tissue regions, uncovering how the MET inhibitor tepotinib transformed the TME in locally advanced NSCLC into a more immune-permissive state. This work underscores how GeoMx DSP delivers integrated insights into health and disease from precious tissue samples, driving breakthroughs in spatial biology and oncology research. Read the full paper: Simard et al., Neoplasia, 2024. 👉 https://lnkd.in/d4XQM9eF #LungCancerAwarenessMonth #GeoMxDSP #DiscoveryMultiomics #SpatialBiology #TumorMicroenvironment

Happy Thanksgiving from Bruker Spatial Biology! We are thankful for many things this year, a key one being you the research community, for continuing to innovate, discover, and push scientific boundaries. #Thanksgiving #SpatialBiology #ScientificInnovation #ThankfulThursday

We're heading to the Oxford Global Spatial Biology US West Coast conference in San Diego as a Diamond Sponsor! Join us on December 4th for our industry workshop, where we’ll showcase how our best-in-class solutions are driving new insights in biology. The session will conclude with a panel discussion on trends, advancements, and the future of spatial biology. Don’t miss it! 👉 https://lnkd.in/g2bfKRDR

Bruker Spatial Biology is proud to be a Platinum Sponsor at Multi-Omics 2024! Join Joe Beechem and Oliver Braubach as they showcase our best-in-class solutions for spatial biology research. Discover how our cutting-edge platforms empower researchers to explore tissues like never before, with the most comprehensive suite of technologies spanning spatial transcriptomics, proteomics, and genomics. Don’t miss this opportunity to learn how we’re transforming spatial multiomics research. 🔬 Learn more about Bruker Spatial Biology here: https://lnkd.in/di3nQDAS #SpatialBiology #MultiOmics2024 #SpatialTranscriptomics #Proteomics #Genomics #Innovation #BrukerSpatialBiology

HIV latency remains a key barrier to a cure, with limited biomarkers to identify dormant, infected cells. This #FridayRead spotlights how Merck researchers, led by Guoxin Wu, are tackling this with CosMx Spatial Molecular Imager, using single-cell spatial transcriptomics to profile HIV-infected cells and uncover host biomarkers linked to HIV reservoirs. Read more in Biomarker Research 👉 https://lnkd.in/gSxR2gzK #Virology #SingleCellSpatial #HIV

We recently spoke with Massimo Andreatta, a researcher at the University of Lausanne, about his team's use of the CosMx Human 6K Discovery panel, which provides over 6,000-plex, to explore gene programs tied to clinical outcomes in basal cell carcinoma. With the highest single-cell plex available, CosMx SMI enables broader biological insights with unmatched precision. Next steps include expanding the study to a larger patient cohort and other skin cancers to validate their findings. 🎧 Listen to his testimonial and learn more about the CosMx Human 6K Discovery RNA panel 👉 https://lnkd.in/g2ZF3wMi #SingleCellSpatial #SkinCancer #CosMxSMI #SpatialTranscriptomics

This #FridayRead dives into the role of intra-tumoral B cells in anti-tumor immunity, serving as positive prognostic biomarkers in solid tumors, including ovarian cancer. Using CellScape Precise Spatial Proteomics, researchers mapped the spatial distribution of immune cells in ovarian tumors, uncovering antibody-secreting B cells exposed to Epstein-Barr Virus. Discover more 👉https://lnkd.in/g7EVRcMW #CancerResearch #OvarianCancer #SpatialProteomics #FridayRead

Transplant rejection is a hot topic these days! We're thrilled to welcome guest speaker Dr. Marian Clahsen-van Groningen MD, PhD of Erasmus University for a webinar on Molecular Analysis of Allograft Biopsies; Changing the Future of Transplant Research. Join us next week on November 19th to learn how cutting-edge technologies, such as #nCounter gene expression analysis in combination with multiplex #immunofluorescence, are revolutionizing the detection and characterization of transplant rejection and other pathologies. https://lnkd.in/g_g8x55n #OrganTransplantResearch #nCounter